263700 — Carelabs Co Income Statement
0.000.00%
Last trade - 00:00- KR₩59bn
- KR₩80bn
- KR₩83bn
- 41
- 38
- 56
- 41
Annual income statement for Carelabs Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 76,666 | 93,934 | 87,607 | 81,827 | 83,187 |
| Cost of Revenue | |||||
| Gross Profit | 73,509 | 89,250 | 84,637 | 79,736 | 82,141 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 75,250 | 92,787 | 105,004 | 97,361 | 93,922 |
| Operating Profit | 1,417 | 1,147 | -17,397 | -15,534 | -10,735 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 6,195 | 3,936 | -26,789 | -21,648 | -19,139 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 4,518 | 1,242 | -26,388 | -23,867 | -19,670 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 4,329 | 1,253 | -26,124 | -24,470 | -20,280 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | 4,909 | 1,253 | -26,124 | -24,470 | -20,280 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 476 | 152 | -994 | -1,144 | -685 |
| Dividends per Share |